A detailed history of Reynders Mc Veigh Capital Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Reynders Mc Veigh Capital Management, LLC holds 4,582 shares of EW stock, worth $300,029. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,582
Previous 4,582 -0.0%
Holding current value
$300,029
Previous $438,000 3.42%
% of portfolio
0.02%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$72.54 - $95.56 $332,378 - $437,855
4,582 New
4,582 $438,000
Q4 2023

Feb 07, 2024

BUY
$61.71 - $77.76 $38,568 - $48,600
625 Added 12.95%
5,452 $416,000
Q3 2023

Nov 09, 2023

SELL
$69.28 - $93.38 $25,910 - $34,924
-374 Reduced 7.19%
4,827 $334,000
Q2 2023

Aug 09, 2023

SELL
$81.41 - $94.33 $13,432 - $15,564
-165 Reduced 3.07%
5,201 $491,000
Q1 2023

May 03, 2023

BUY
$74.26 - $84.51 $20,421 - $23,240
275 Added 5.4%
5,366 $444,000
Q4 2022

Feb 10, 2023

SELL
$68.3 - $87.44 $5,259 - $6,732
-77 Reduced 1.49%
5,091 $380,000
Q3 2022

Nov 08, 2022

BUY
$82.37 - $107.29 $86,900 - $113,190
1,055 Added 25.65%
5,168 $427,000
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $106 - $130
-1 Reduced 0.02%
4,113 $533,000
Q2 2021

Aug 12, 2021

SELL
$83.84 - $104.76 $7,294 - $9,114
-87 Reduced 2.07%
4,114 $426,000
Q1 2021

May 07, 2021

BUY
$78.68 - $90.67 $236 - $272
3 Added 0.07%
4,201 $351,000
Q4 2020

Feb 10, 2021

BUY
$71.69 - $91.23 $286 - $364
4 Added 0.1%
4,198 $383,000
Q3 2020

Oct 28, 2020

SELL
$67.19 - $87.44 $5,643 - $7,344
-84 Reduced 1.96%
4,194 $335,000
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $167,614 - $224,155
2,913 Added 213.41%
4,278 $296,000
Q1 2020

May 13, 2020

BUY
$52.41 - $81.0 $419 - $648
8 Added 0.59%
1,365 $257,000
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $97,296 - $111,396
1,357 New
1,357 $317,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Reynders Mc Veigh Capital Management, LLC Portfolio

Follow Reynders Mc Veigh Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.